Global Pharmaceuticals & Biotech Profitable Climbers

Eris Lifesciences

Market Cap: ₹244.7b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.6b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Labiana Health

Market Cap: €27.6m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

SIGA Technologies

Market Cap: US$653.8m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Shanghai OPM Biosciences

Market Cap: CN¥6.6b

Provides cell culture media and CDMO services in China and internationally.

Anthem Biosciences

Market Cap: ₹473.8b

Operates as technology-focused contract research, development, and manufacturing organization.

Senores Pharmaceuticals

Market Cap: ₹33.1b

Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.

BioGaia

Market Cap: SEK 10.0b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Neuphoria Therapeutics

Market Cap: US$13.5m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Egyptian International Pharmaceutical Industries

Market Cap: ج.م9.0b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

Cosmo Pharmaceuticals

Market Cap: CHF 929.2m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Medexus Pharmaceuticals

Market Cap: CA$92.6m

Operates as a pharmaceutical company in Canada and the United States.

Krystal Biotech

Market Cap: US$4.4b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Eli Lilly

Market Cap: US$624.2b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

ChengDu ShengNuo BiotecLtd

Market Cap: CN¥6.9b

Engages in the research and development, production, sale, and export of peptide drugs.

Protalix BioTherapeutics

Market Cap: US$132.4m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Earth Science Tech

Market Cap: US$61.8m

Together with its subsidies, focuses on health and wellness industry.

Jenkem Technology

Market Cap: CN¥6.0b

Develops and manufactures polyethylene glycol derivative (PEG) products in China.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥18.9b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

SynBiotic

Market Cap: €24.5m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Protagonist Therapeutics

Market Cap: US$3.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Inner Mongolia Furui Medical Science

Market Cap: CN¥16.7b

Inner Mongolia Furui Medical Science Co., Ltd.

Beijing Konruns PharmaceuticalLtd

Market Cap: CN¥8.4b

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

Teyi Pharmaceutical GroupLtd

Market Cap: CN¥4.7b

Engages in the research and development, production, and sale of Chinese patent medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China.

Telix Pharmaceuticals

Market Cap: AU$6.3b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Beijing Sun-Novo Pharmaceutical Research

Market Cap: CN¥8.7b

A contract research company, engages in the research and development of drugs in China.

Shilpa Medicare

Market Cap: ₹73.8b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.

Supriya Lifescience

Market Cap: ₹53.3b

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

Sandoz Group

Market Cap: CHF 21.8b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Kamada

Market Cap: ₪1.4b

Manufactures and sells plasma-derived protein therapeutics.

Genomma Lab Internacional. de

Market Cap: Mex$21.5b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Exelixis

Market Cap: US$10.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Niagen Bioscience

Market Cap: US$797.6m

Operates as a bioscience company engages in developing healthy aging products.

AFT Pharmaceuticals

Market Cap: NZ$275.8m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Hanall Biopharma

Market Cap: ₩1.5t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.